Cabometyx 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMEH1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,136
Award facts
- Contract value 100% obligated
- $53,136.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,136.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). The delivery order, issued on January 28, 2026, with an ultimate completion date of January 29, 2026, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling value under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors to supply a comprehensive range of pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's contract, designated SPE2DR, features a 30-month base period with three 30-month option periods extending through December 31, 2036, and authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. Cabometyx, an oncology treatment, exemplifies the specialized pharmaceutical products the contractor supplies to support global military medical operations, with no subcontractors identified in this award.
Quick answers
Who was awarded contract SPE2DR26FMEH1?
SPE2DR26FMEH1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMEH1 worth?
The government has obligated $53,136 on SPE2DR26FMEH1.
Is contract SPE2DR26FMEH1 an order under another contract?
Yes. SPE2DR26FMEH1 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEH1 competed?
The extent of competition for SPE2DR26FMEH1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award